
Participants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.
Karen M. Alsante, PhD, is a senior research investigator at Pfizer Global Research and Development (Groton, CT).

Participants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.

Published: February 1st 2002 | Updated: